A Short DNA Aptamer That Recognizes TNFα and Blocks Its Activity in Vitro

Citations Over TimeTop 15% of 2012 papers

Abstract

Tumor necrosis factor-alpha (TNFα) is a pivotal component of the cytokine network linked to inflammatory diseases. Protein-based, TNFα inhibitors have proven to be clinically valuable. Here, we report the identification of short, single-stranded DNA aptamers that bind specifically to human TNFα. One such 25-base long aptamer, termed VR11, was shown to inhibit TNFα signaling as measured using NF-κB luciferase reporter assays. This aptamer bound specifically to TNFα with a dissociation constant of 7.0 ± 2.1 nM as measured by surface plasmon resonance (SPR) and showed no binding to TNFβ. Aptamer VR11 was also able to prevent TNFα-induced apoptosis as well as reduce nitric oxide (NO) production in cultured cells for up to 24 h. As well, VR11, which contains a GC rich region, did not raise an immune response when injected intraperitoneally into C57BL/6 mice when compared to a CpG oligodeoxynucleotide (ODN) control, a known TLR9 ligand. These studies suggest that VR11 may represent a simpler, synthetic scaffold than antibodies or protein domains upon which to derive nonimmunogenic oligonucleotide-based inhibitors of TNFα.

Related Papers

• → Aptamer cocktails: Enhancement of sensing signals compared to single use of aptamers for detection of bacteria(2013)87 cited
• → An aptamer cocktail-based electrochemical aptasensor for direct capture and rapid detection of tetracycline in honey(2019)40 cited
• → Idiosyncrasies of Thermofluorimetric Aptamer Binding Assays(2019)10 cited
• → Selecting DNA aptamers for endotoxin separation(2015)5 cited
• → Aptameric sensors based on structural change for diagnosis(2010)9 cited